GlaxoSmithKline, CureVac, Airbnb and more

Take a look at some of the biggest movers in the premarket: GlaxoSmithKline (GSK) – The drugmaker’s U.S.-listed shares jumped 3.1% in the premarket following a Bloomberg report that the … Read More

Revolut, the $33 billion fintech player, is rolling out commission-free stock trading in the U.S.

Revolut CEO Nikolay Storonsky speaks onstage at the TechCrunch Disrupt conference in San Francisco, California. Kimberly White | Getty Images Revolut, the global fintech player valued at $33 billion, will … Read More